News 2024-03-08
Join Our Founder and CEO @ DCAT Week
Join Our Founder and CEO @ DCAT Week
What:
DCAT Member Company Announcement Forum
When:
10:36-10:43AM, on Monday March 18, 2024
Where:
InterContinental Barclay, Grand Ballroom (2nd Floor)
Porton Pharma Solutions Ltd (hereinafter referred to as Porton or the Company) will participate in the DCAT Week which will be held in New York, from March 18-21, 2024.
As the premiere event in New York City for the Global Bio/Pharmaceutical Manufacturing Value Chain, DCAT Week garners annual industry attention. Porton has consistently participated in this esteemed gathering. At this year’s conference, our Chairman & CEO, Oliver Ju, is scheduled to speak at the DCAT Member Company Announcement Forum on the opening day. He will unveil our latest European and US facilities and capabilities, highlighting how these expansions streamline and enhance our ability to meet your unique development needs with greater ease.
Throughout DCAT Week, the Porton management team, our business development (BD) specialists, and our scientists are eager to connect with you in New York.
Schedule a meeting with us: Arsalan Khan
Others
More
News 2026-09-17
Porton Congratulates Partner Acepodia on FDA and NMPA IND Approvals for ACE723, a Dual-Payload ADC
This project demonstrates Porton's process-development and scale-up capabilities for complex conjugates and adds to its experience supporting innovative biopharma companies worldwide.
News 2026-09-15
Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001
This successful recertification highlights the standardized operation of the site's management systems, the rigor of its on-site management, and the robustness of its risk control mechanisms, further validating the continued effectiveness of the dual systems.
